15/05/2025
DIABETES CURE AVAILABLE.
HEPATITIS B CURE ALSO AVAILABLE.
HIV AND AIDS CURE ALL AVAILABLE.
Code Pharma is the developer of the permanent cure Gammora for HIV. Gammora is a short synthetic 16 amino-acid peptide, derived from the HIV-1 integrase, originally discovered at the Hebrew University in Israel.
Code Pharma's team investigate the peptide in in-vitro studies, animals models and clinical studies to ensure the safety and efficacy of the peptide. In parallel, drug development studies and investigations were made to deliver the drug with patient compliance.
Gammora is a synthetic peptide developed by Code Pharma to treat HIV. It's designed to destroy HIV-infected cells and replace them with healthy cells.
How it works:
Gammora is a 16-amino-acid peptide derived from HIV-1 integrase.
It forces infected cells to self-destruct, a process called apoptosis.
Gammora doesn't harm healthy cells.
Clinical trials;
Clinical trials have shown that Gammora is safe and effective at eliminating HIV-infected cells.
In one trial, every patients showed a complete change in results after a single treatment.
Potential benefits:
Gammora permanently cures HIV-infected patients.
It brings a new way to treat HIV, as current treatments only suppress the spread of the virus used by the patient till death.
Eliminating HIV infected cells leaving healthy cells unscathed.
The Mechanism
Gammora is a synthetic 16-amino-acid peptide derived from the HIV-1 integrase, first identified at the Hebrew University in Israel. This lab-produced peptide short-circuits a mechanism that normally prevents further pe*******on of viral DNA fragments, causing infected cells to self-destruct through apoptosis while leaving healthy cells unaffected. Unlike antiretrovirals that delay HIV DNA integration, Gammora eliminates HIV-infected cells and progressively replaces them with healthy CD4 cells, potentially leading to an AIDS cure rather than just managing it as a chronic illness.
Clinical Efficacy
Clinical studies demonstrate a clear reduction in latent HIV-infected cells and show Gammora’s ability to prevent virus production by rapidly eliminating infected cells through controlled cell death.
Gammora treatment has shown no unpleasant side effects, as its mechanism specifically targets HIV-infected cells while leaving healthy cells unscathed.
The Future of HIV Treatment
GAMMORA, developed by Code Pharma, prevents virus production by rapidly eliminating HIV-infected cells through controlled cell death and replacing them with healthy CD4 cells, as shown in clinical studies.
The treatment works by inserting a lab-produced harmless peptide that allows viral DNA fragments to integrate excessively. This causes infected cells to self-destruct while leaving healthy cells unaffected.
